サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1786335

COVID-19ドラッグデリバリー・デバイスの世界市場

COVID-19 Drug Delivery Devices

出版日
ページ情報
英文 277 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.66円
COVID-19ドラッグデリバリー・デバイスの世界市場
出版日: 2025年08月08日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 277 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

COVID-19ドラッグデリバリー・デバイスの世界市場は2030年までに16億米ドルに達する見込み

2024年に16億米ドルと推定されるCOVID-19ドラッグデリバリー・デバイスの世界市場は、2030年には16億米ドルに達し、分析期間2024-2030年のCAGRは-0.1%で成長すると予測されます。本レポートで分析したセグメントの1つであるプレフィルドシリンジは、CAGR 0.0％を記録し、分析期間終了時には7億9,060万米ドルに達すると予測されます。ニードルフリー注射器セグメントの成長率は、分析期間中CAGRマイナス0.3％と推定されます。

米国市場は4億4,580万米ドルと推定、中国はCAGR 0.1％で成長予測

米国のCOVID-19ドラッグデリバリー・デバイス市場は、2024年には4億4,580万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024-2030年のCAGR 0.1％を引きずる形で、2030年までに2億7,680万米ドルの市場規模に達すると予測されています。その他の注目すべき地域市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ-0.2％と-0.1％と予測されています。欧州では、ドイツのCAGRが約-0.2%と予測されています。

世界のCOVID-19ドラッグデリバリー・デバイス市場- 主要動向と促進要因のまとめ

パンデミックはドラッグデリバリーをどう変えたか？ヘルスケアの優先順位の変化を理解する

COVID-19のパンデミックは世界のヘルスケア産業を再構築し、抗ウイルス治療薬やワクチンの効率的かつ安全な投与を確実にする高度なドラッグデリバリーデバイスへの需要を加速させました。COVID-19ワクチンの急速な開発とデリバリーは、注射器と自動注射器の製造拡大を必要とし、ドラッグデリバリーデバイス市場のかつてない成長につながりました。さらに、COVID-19入院患者の急増により、呼吸器合併症の管理のための吸入・ネブライゼーション療法の改善が必要となりました。パンデミックはまた、自己投与ドラッグデリバリーソリューションの重要性を浮き彫りにし、プレフィルドシリンジ、自動注射器、ウェアラブルドラッグデリバリーシステムへのシフトを促しました。遠隔医療統合と在宅ヘルスケアソリューションは、遠隔モニタリングと投与量追跡を可能にするスマート薬物送達デバイスの需要をさらに高めました。さらに、世界の大流行への備えが重視されるようになったことで、政府や製薬会社は拡張性のある効率的なドラッグデリバリーインフラへの投資を促しています。

最も需要の高いドラッグデリバリーデバイスは？主要製品セグメントを探る

COVID-19ドラッグデリバリー・デバイス市場は、注射器、吸入器、自己注射器、輸液ポンプ、経皮吸収パッチなど、さまざまなセグメントで構成されています。プレフィルドシリンジはワクチン投与において最も重要なコンポーネントの一つであり、メーカーは世界の需要に対応するために生産を拡大しています。ネブライザーやドライパウダー吸入器などの吸入ドラッグデリバリーシステムは、特にリスクの高い患者の間で、COVID-19関連の呼吸器合併症の管理に重要な役割を果たしています。インスリンポンプやスマートインジェクターなどのウェアラブルドラッグデリバリーデバイスは、患者が非接触で自己投与可能な治療ソリューションを求めていることから、支持を集めています。さらに、ワクチンデリバリー用のマイクロニードルパッチの出現は、従来の注射に代わる新たな選択肢を導入し、コールドチェーン保管の必要性を減らし、遠隔地でのアクセシビリティを向上させています。また、針刺し事故や患者のコンプライアンスに対する懸念から、針を使わないドラッグデリバリーシステムへのシフトも加速しています。

イノベーションはCOVID-19ドラッグデリバリーにどのような革命をもたらしているのか？AI、ナノテクノロジー、スマートデバイスの役割

パンデミックはドラッグデリバリー・デバイスの技術革新を促し、より効率的で患者に優しいソリューションの開発につながりました。リアルタイムの症状追跡機能を備えたAI主導の吸入器は、特に長期のCOVID-19合併症に対する呼吸器治療のアドヒアランスを向上させました。ドラッグデリバリーにおけるナノテクノロジーの統合は、COVID-19治療薬のバイオアベイラビリティと標的作用を改善し、副作用を最小限に抑えて治療成果を最適化しています。さらに、遠隔接続機能を備えたスマート・ドラッグデリバリー・デバイスは、患者の遠隔モニタリングを容易にし、病院への通院を減らし、ヘルスケアへのアクセスを向上させています。温度安定性の高いワクチン製剤の開発と注射針を使わない送達システムの組み合わせにより、集団予防接種キャンペーンに伴う物流の課題に対処しています。さらに、バイオ医薬品の進歩により、長時間作用型の抗ウイルス製剤が開発され、薬剤投与の頻度を減らし、治療効果を高めています。

何がCOVID-19ドラッグデリバリー・デバイス市場の成長を牽引しているのか？主な市場インフルエンサーを解説

COVID-19ドラッグデリバリー・デバイス市場の成長は、世界の予防接種の増加、ドラッグデリバリー技術の進歩、自己投与による治療選択肢の拡大など、いくつかの要因によって牽引されています。バイオ医薬品への投資の増加は、次世代ドラッグデリバリーソリューションの開発を加速させ、患者のコンプライアンスと治療成果を向上させています。eコマースやデジタルヘルスケアプラットフォームの拡大も、自己投与型ドラッグデリバリーデバイスの普及を促進しています。さらに、パンデミックへの備えを目的とした政府の取り組みにより、スケーラブルなワクチン配布や緊急医療サプライチェーンへの資金援助が増加しています。個別化医療や標的を絞ったドラッグデリバリーアプローチへのシフトは、市場の成長をさらに強めています。パンデミック後のヘルスケア産業が進化を続ける中、イノベーション、デジタル統合、世界ヘルスケアインフラの強化によって、COVID-19ドラッグデリバリー・デバイス市場の拡大が見込まれています。

セグメント

製品（プレフィルドシリンジ、ニードルフリー注射器、吸入器、パッチ）、投与経路（非経口投与、経鼻投与、その他の投与）、流通チャネル（病院薬局、小売薬局、オンライン薬局）

調査対象企業の例

  • ApiJect Systems Corp.
  • AstraZeneca plc
  • Becton, Dickinson and Company（BD）
  • Bharat Biotech
  • CanSino Biologics Inc.
  • Cardinal Health
  • Croda International Plc
  • Gerresheimer AG
  • GlaxoSmithKline plc（GSK）
  • Hindustan Syringes & Medical Devices Ltd.
  • Inovio Pharmaceuticals
  • Johnson & Johnson
  • Moderna, Inc.
  • Novartis International AG
  • Pfizer Inc.
  • Sanofi S.A.
  • SCHOTT AG
  • Serum Institute of India Pvt. Ltd.
  • Sinovac Biotech Ltd.
  • Terumo Corporation

AIインテグレーション

当社は、有効な専門家コンテンツとAIツールにより、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP30276

Global COVID-19 Drug Delivery Devices Market to Reach US$1.6 Billion by 2030

The global market for COVID-19 Drug Delivery Devices estimated at US$1.6 Billion in the year 2024, is expected to reach US$1.6 Billion by 2030, growing at a CAGR of -0.1% over the analysis period 2024-2030. Prefilled Syringe, one of the segments analyzed in the report, is expected to record a 0.0% CAGR and reach US$790.6 Million by the end of the analysis period. Growth in the Needle-free Injectors segment is estimated at -0.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$445.8 Million While China is Forecast to Grow at 0.1% CAGR

The COVID-19 Drug Delivery Devices market in the U.S. is estimated at US$445.8 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$276.8 Million by the year 2030 trailing a CAGR of 0.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of -0.2% and -0.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately -0.2% CAGR.

Global COVID-19 Drug Delivery Devices Market - Key Trends & Drivers Summarized

How Has the Pandemic Transformed Drug Delivery? Understanding the Shift in Healthcare Priorities

The COVID-19 pandemic has reshaped the global healthcare industry, accelerating the demand for advanced drug delivery devices to ensure efficient and safe administration of antiviral treatments and vaccines. The rapid development and distribution of COVID-19 vaccines necessitated the expansion of syringe and auto-injector manufacturing, leading to unprecedented growth in the drug delivery devices market. Additionally, the surge in hospitalized COVID-19 patients required improved inhalation and nebulization therapies for managing respiratory complications. The pandemic also underscored the importance of self-administered drug delivery solutions, prompting a shift toward prefilled syringes, autoinjectors, and wearable drug delivery systems. Telemedicine integration and at-home healthcare solutions have further increased demand for smart drug delivery devices that enable remote monitoring and dosage tracking. Additionally, the rising emphasis on global pandemic preparedness has prompted governments and pharmaceutical companies to invest in scalable and efficient drug delivery infrastructure.

Which Drug Delivery Devices Have Seen the Highest Demand? Exploring Key Product Segments

The COVID-19 drug delivery devices market comprises various segments, including syringes, inhalers, autoinjectors, infusion pumps, and transdermal patches. Prefilled syringes have been one of the most critical components in vaccine administration, with manufacturers ramping up production to meet global demand. Inhalation drug delivery systems, including nebulizers and dry powder inhalers, have played a crucial role in managing COVID-19-related respiratory complications, particularly among high-risk patients. Wearable drug delivery devices, such as insulin pumps and smart injectors, have gained traction as patients seek contactless and self-administered treatment solutions. Additionally, the emergence of microneedle patches for vaccine delivery has introduced a novel alternative to traditional injections, reducing the need for cold-chain storage and improving accessibility in remote regions. The shift toward needle-free drug delivery systems has also accelerated, driven by concerns over needle-stick injuries and patient compliance.

How Is Innovation Revolutionizing COVID-19 Drug Delivery? The Role of AI, Nanotechnology & Smart Devices

The pandemic has driven a wave of technological innovations in drug delivery devices, leading to the development of more efficient, patient-friendly solutions. AI-driven inhalers equipped with real-time symptom tracking have enhanced respiratory treatment adherence, particularly for long-term COVID-19 complications. The integration of nanotechnology in drug delivery has improved the bioavailability and targeted action of COVID-19 therapeutics, minimizing side effects and optimizing treatment outcomes. Additionally, smart drug delivery devices with remote connectivity features have facilitated remote patient monitoring, reducing hospital visits and improving healthcare accessibility. The development of temperature-stable vaccine formulations, combined with needle-free delivery systems, has addressed logistical challenges associated with mass immunization campaigns. Furthermore, advancements in biopharmaceuticals have led to the creation of long-acting antiviral formulations, reducing the frequency of drug administration and enhancing treatment efficacy.

What’s Driving the Growth of the COVID-19 Drug Delivery Devices Market? Key Market Influencers Explained

The growth in the COVID-19 drug delivery devices market is driven by several factors, including increased global immunization efforts, advancements in drug delivery technology, and the expansion of self-administered treatment options. The rising investment in biopharmaceuticals has accelerated the development of next-generation drug delivery solutions, improving patient compliance and therapeutic outcomes. The expansion of e-commerce and digital healthcare platforms has also facilitated the widespread availability of self-administration drug delivery devices. Additionally, government initiatives aimed at pandemic preparedness have led to increased funding for scalable vaccine distribution and emergency medical supply chains. The shift toward personalized medicine and targeted drug delivery approaches has further strengthened market growth. As the healthcare industry continues to evolve post-pandemic, the COVID-19 drug delivery devices market is expected to expand, driven by innovation, digital integration, and enhanced global healthcare infrastructure.

SCOPE OF STUDY:

The report analyzes the COVID-19 Drug Delivery Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Prefilled Syringe, Needle-free Injectors, Inhalers, Patches); Route of Administration (Parenteral Administration, Nasal Administration, Other Administrations); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 43 Featured) -

  • ApiJect Systems Corp.
  • AstraZeneca plc
  • Becton, Dickinson and Company (BD)
  • Bharat Biotech
  • CanSino Biologics Inc.
  • Cardinal Health
  • Croda International Plc
  • Gerresheimer AG
  • GlaxoSmithKline plc (GSK)
  • Hindustan Syringes & Medical Devices Ltd.
  • Inovio Pharmaceuticals
  • Johnson & Johnson
  • Moderna, Inc.
  • Novartis International AG
  • Pfizer Inc.
  • Sanofi S.A.
  • SCHOTT AG
  • Serum Institute of India Pvt. Ltd.
  • Sinovac Biotech Ltd.
  • Terumo Corporation

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • COVID-19 Drug Delivery Devices - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Surge in Global Vaccine Distribution Drives Demand for Efficient COVID-19 Drug Delivery Devices
    • Growing Focus on Vaccine Equity and Accessibility Expands Addressable Market for Affordable Drug Delivery Solutions
    • Innovation in Needle-Free and Non-Invasive Drug Delivery Technologies Accelerates Adoption for COVID-19 Vaccines
    • Increasing Government Support and Funding for Vaccine Rollout Programs Propels Growth in Drug Delivery Device Development
    • Technological Advancements in Microneedle Patches Strengthen the Business Case for Non-Traditional Vaccine Delivery Methods
    • The Need for Mass Immunization Drives Adoption of Scalable, High-Efficiency Drug Delivery Devices
    • Rising Preference for Self-Administration and At-Home Vaccine Delivery Solutions Expands Market Opportunities
    • Expansion of Cold Chain Logistics and Temperature-Sensitive Packaging Solutions Supports Growth in Drug Delivery Devices
    • Heightened Focus on Global Pandemic Preparedness Stimulates Innovation in Rapid Response Drug Delivery Systems
    • Regulatory Approvals for Emergency Use Authorizations (EUAs) Accelerate the Development and Distribution of COVID-19 Drug Delivery Devices
    • Consumer Trust in New Vaccine Technologies Drives Demand for Safe, Reliable Drug Delivery Mechanisms
    • Global Push for Digital Health Solutions Expands Adoption of Connected Drug Delivery Devices with IoT Integration
    • Increasing Public-Private Partnerships for Vaccine Research and Development Expands Opportunities for Drug Delivery Device Manufacturers
    • Rise in Immunocompromised Populations and Increased Health Risks Post-Pandemic Sustains Demand for Effective Drug Delivery Systems
    • Growth in Collaborative Research Between Pharma Companies and Tech Firms Drives Innovation in Delivery Device Designs
    • Push for Streamlined Healthcare Supply Chains Strengthens Market Demand for Cost-Effective Drug Delivery Solutions
    • Emergence of New Variants of COVID-19 Drives Demand for Advanced, Flexible Drug Delivery Devices to Address Evolving Therapeutic Needs
    • Increased Investment in AI and Machine Learning for Personalized Vaccine Dosing Expands Market Potential for Smart Drug Delivery Systems
    • Rising Focus on Patient Comfort and Experience Spurs Growth in Painless and Low-Discomfort Delivery Devices
    • Evolving Regulatory Landscape and Compliance Challenges in Vaccine Delivery Highlight the Need for Robust, Adaptable Drug Delivery Solutions
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World COVID-19 Drug Delivery Devices Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for COVID-19 Drug Delivery Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Prefilled Syringe by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Prefilled Syringe by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Needle-free Injectors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Needle-free Injectors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Inhalers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Inhalers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Patches by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Patches by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Online Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Online Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Hospital Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Retail Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Parenteral Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Parenteral Administration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Nasal Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for Nasal Administration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Other Administrations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 23: World 6-Year Perspective for Other Administrations by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • COVID-19 Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 24: USA Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Product - Prefilled Syringe, Needle-free Injectors, Inhalers and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 25: USA 6-Year Perspective for COVID-19 Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled Syringe, Needle-free Injectors, Inhalers and Patches for the Years 2025 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA 6-Year Perspective for COVID-19 Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2025 & 2030
    • TABLE 28: USA Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Route Of Administration - Parenteral Administration, Nasal Administration and Other Administrations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 29: USA 6-Year Perspective for COVID-19 Drug Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Parenteral Administration, Nasal Administration and Other Administrations for the Years 2025 & 2030
  • CANADA
    • TABLE 30: Canada Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Product - Prefilled Syringe, Needle-free Injectors, Inhalers and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 31: Canada 6-Year Perspective for COVID-19 Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled Syringe, Needle-free Injectors, Inhalers and Patches for the Years 2025 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada 6-Year Perspective for COVID-19 Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2025 & 2030
    • TABLE 34: Canada Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Route Of Administration - Parenteral Administration, Nasal Administration and Other Administrations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 35: Canada 6-Year Perspective for COVID-19 Drug Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Parenteral Administration, Nasal Administration and Other Administrations for the Years 2025 & 2030
  • JAPAN
    • COVID-19 Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 36: Japan Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Product - Prefilled Syringe, Needle-free Injectors, Inhalers and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 37: Japan 6-Year Perspective for COVID-19 Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled Syringe, Needle-free Injectors, Inhalers and Patches for the Years 2025 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan 6-Year Perspective for COVID-19 Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2025 & 2030
    • TABLE 40: Japan Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Route Of Administration - Parenteral Administration, Nasal Administration and Other Administrations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 41: Japan 6-Year Perspective for COVID-19 Drug Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Parenteral Administration, Nasal Administration and Other Administrations for the Years 2025 & 2030
  • CHINA
    • COVID-19 Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 42: China Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Product - Prefilled Syringe, Needle-free Injectors, Inhalers and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 43: China 6-Year Perspective for COVID-19 Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled Syringe, Needle-free Injectors, Inhalers and Patches for the Years 2025 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China 6-Year Perspective for COVID-19 Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2025 & 2030
    • TABLE 46: China Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Route Of Administration - Parenteral Administration, Nasal Administration and Other Administrations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 47: China 6-Year Perspective for COVID-19 Drug Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Parenteral Administration, Nasal Administration and Other Administrations for the Years 2025 & 2030
  • EUROPE
    • COVID-19 Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 48: Europe Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 49: Europe 6-Year Perspective for COVID-19 Drug Delivery Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Product - Prefilled Syringe, Needle-free Injectors, Inhalers and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe 6-Year Perspective for COVID-19 Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled Syringe, Needle-free Injectors, Inhalers and Patches for the Years 2025 & 2030
    • TABLE 52: Europe Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 53: Europe 6-Year Perspective for COVID-19 Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2025 & 2030
    • TABLE 54: Europe Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Route Of Administration - Parenteral Administration, Nasal Administration and Other Administrations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 55: Europe 6-Year Perspective for COVID-19 Drug Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Parenteral Administration, Nasal Administration and Other Administrations for the Years 2025 & 2030
  • FRANCE
    • COVID-19 Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Product - Prefilled Syringe, Needle-free Injectors, Inhalers and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France 6-Year Perspective for COVID-19 Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled Syringe, Needle-free Injectors, Inhalers and Patches for the Years 2025 & 2030
    • TABLE 58: France Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 59: France 6-Year Perspective for COVID-19 Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2025 & 2030
    • TABLE 60: France Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Route Of Administration - Parenteral Administration, Nasal Administration and Other Administrations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 61: France 6-Year Perspective for COVID-19 Drug Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Parenteral Administration, Nasal Administration and Other Administrations for the Years 2025 & 2030
  • GERMANY
    • COVID-19 Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Product - Prefilled Syringe, Needle-free Injectors, Inhalers and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany 6-Year Perspective for COVID-19 Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled Syringe, Needle-free Injectors, Inhalers and Patches for the Years 2025 & 2030
    • TABLE 64: Germany Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Germany 6-Year Perspective for COVID-19 Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2025 & 2030
    • TABLE 66: Germany Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Route Of Administration - Parenteral Administration, Nasal Administration and Other Administrations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Germany 6-Year Perspective for COVID-19 Drug Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Parenteral Administration, Nasal Administration and Other Administrations for the Years 2025 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Product - Prefilled Syringe, Needle-free Injectors, Inhalers and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy 6-Year Perspective for COVID-19 Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled Syringe, Needle-free Injectors, Inhalers and Patches for the Years 2025 & 2030
    • TABLE 70: Italy Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 71: Italy 6-Year Perspective for COVID-19 Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2025 & 2030
    • TABLE 72: Italy Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Route Of Administration - Parenteral Administration, Nasal Administration and Other Administrations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 73: Italy 6-Year Perspective for COVID-19 Drug Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Parenteral Administration, Nasal Administration and Other Administrations for the Years 2025 & 2030
  • UNITED KINGDOM
    • COVID-19 Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Product - Prefilled Syringe, Needle-free Injectors, Inhalers and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK 6-Year Perspective for COVID-19 Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled Syringe, Needle-free Injectors, Inhalers and Patches for the Years 2025 & 2030
    • TABLE 76: UK Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 77: UK 6-Year Perspective for COVID-19 Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2025 & 2030
    • TABLE 78: UK Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Route Of Administration - Parenteral Administration, Nasal Administration and Other Administrations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 79: UK 6-Year Perspective for COVID-19 Drug Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Parenteral Administration, Nasal Administration and Other Administrations for the Years 2025 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Product - Prefilled Syringe, Needle-free Injectors, Inhalers and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain 6-Year Perspective for COVID-19 Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled Syringe, Needle-free Injectors, Inhalers and Patches for the Years 2025 & 2030
    • TABLE 82: Spain Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Spain 6-Year Perspective for COVID-19 Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2025 & 2030
    • TABLE 84: Spain Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Route Of Administration - Parenteral Administration, Nasal Administration and Other Administrations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Spain 6-Year Perspective for COVID-19 Drug Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Parenteral Administration, Nasal Administration and Other Administrations for the Years 2025 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Product - Prefilled Syringe, Needle-free Injectors, Inhalers and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia 6-Year Perspective for COVID-19 Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled Syringe, Needle-free Injectors, Inhalers and Patches for the Years 2025 & 2030
    • TABLE 88: Russia Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Russia 6-Year Perspective for COVID-19 Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2025 & 2030
    • TABLE 90: Russia Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Route Of Administration - Parenteral Administration, Nasal Administration and Other Administrations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Russia 6-Year Perspective for COVID-19 Drug Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Parenteral Administration, Nasal Administration and Other Administrations for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Product - Prefilled Syringe, Needle-free Injectors, Inhalers and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe 6-Year Perspective for COVID-19 Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled Syringe, Needle-free Injectors, Inhalers and Patches for the Years 2025 & 2030
    • TABLE 94: Rest of Europe Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 95: Rest of Europe 6-Year Perspective for COVID-19 Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2025 & 2030
    • TABLE 96: Rest of Europe Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Route Of Administration - Parenteral Administration, Nasal Administration and Other Administrations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 97: Rest of Europe 6-Year Perspective for COVID-19 Drug Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Parenteral Administration, Nasal Administration and Other Administrations for the Years 2025 & 2030
  • ASIA-PACIFIC
    • COVID-19 Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific 6-Year Perspective for COVID-19 Drug Delivery Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2025 & 2030
    • TABLE 100: Asia-Pacific Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Product - Prefilled Syringe, Needle-free Injectors, Inhalers and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 101: Asia-Pacific 6-Year Perspective for COVID-19 Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled Syringe, Needle-free Injectors, Inhalers and Patches for the Years 2025 & 2030
    • TABLE 102: Asia-Pacific Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 103: Asia-Pacific 6-Year Perspective for COVID-19 Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Route Of Administration - Parenteral Administration, Nasal Administration and Other Administrations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific 6-Year Perspective for COVID-19 Drug Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Parenteral Administration, Nasal Administration and Other Administrations for the Years 2025 & 2030
  • AUSTRALIA
    • COVID-19 Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 106: Australia Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Product - Prefilled Syringe, Needle-free Injectors, Inhalers and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 107: Australia 6-Year Perspective for COVID-19 Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled Syringe, Needle-free Injectors, Inhalers and Patches for the Years 2025 & 2030
    • TABLE 108: Australia Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 109: Australia 6-Year Perspective for COVID-19 Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2025 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Route Of Administration - Parenteral Administration, Nasal Administration and Other Administrations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia 6-Year Perspective for COVID-19 Drug Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Parenteral Administration, Nasal Administration and Other Administrations for the Years 2025 & 2030
  • INDIA
    • COVID-19 Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 112: India Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Product - Prefilled Syringe, Needle-free Injectors, Inhalers and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 113: India 6-Year Perspective for COVID-19 Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled Syringe, Needle-free Injectors, Inhalers and Patches for the Years 2025 & 2030
    • TABLE 114: India Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 115: India 6-Year Perspective for COVID-19 Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2025 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Route Of Administration - Parenteral Administration, Nasal Administration and Other Administrations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India 6-Year Perspective for COVID-19 Drug Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Parenteral Administration, Nasal Administration and Other Administrations for the Years 2025 & 2030
  • SOUTH KOREA
    • TABLE 118: South Korea Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Product - Prefilled Syringe, Needle-free Injectors, Inhalers and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 119: South Korea 6-Year Perspective for COVID-19 Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled Syringe, Needle-free Injectors, Inhalers and Patches for the Years 2025 & 2030
    • TABLE 120: South Korea Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 121: South Korea 6-Year Perspective for COVID-19 Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2025 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Route Of Administration - Parenteral Administration, Nasal Administration and Other Administrations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea 6-Year Perspective for COVID-19 Drug Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Parenteral Administration, Nasal Administration and Other Administrations for the Years 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 124: Rest of Asia-Pacific Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Product - Prefilled Syringe, Needle-free Injectors, Inhalers and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 125: Rest of Asia-Pacific 6-Year Perspective for COVID-19 Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled Syringe, Needle-free Injectors, Inhalers and Patches for the Years 2025 & 2030
    • TABLE 126: Rest of Asia-Pacific Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 6-Year Perspective for COVID-19 Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2025 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Route Of Administration - Parenteral Administration, Nasal Administration and Other Administrations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific 6-Year Perspective for COVID-19 Drug Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Parenteral Administration, Nasal Administration and Other Administrations for the Years 2025 & 2030
  • LATIN AMERICA
    • COVID-19 Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 130: Latin America Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 131: Latin America 6-Year Perspective for COVID-19 Drug Delivery Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2025 & 2030
    • TABLE 132: Latin America Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Product - Prefilled Syringe, Needle-free Injectors, Inhalers and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 133: Latin America 6-Year Perspective for COVID-19 Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled Syringe, Needle-free Injectors, Inhalers and Patches for the Years 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America 6-Year Perspective for COVID-19 Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2025 & 2030
    • TABLE 136: Latin America Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Route Of Administration - Parenteral Administration, Nasal Administration and Other Administrations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 137: Latin America 6-Year Perspective for COVID-19 Drug Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Parenteral Administration, Nasal Administration and Other Administrations for the Years 2025 & 2030
  • ARGENTINA
    • TABLE 138: Argentina Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Product - Prefilled Syringe, Needle-free Injectors, Inhalers and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 139: Argentina 6-Year Perspective for COVID-19 Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled Syringe, Needle-free Injectors, Inhalers and Patches for the Years 2025 & 2030
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina 6-Year Perspective for COVID-19 Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2025 & 2030
    • TABLE 142: Argentina Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Route Of Administration - Parenteral Administration, Nasal Administration and Other Administrations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 143: Argentina 6-Year Perspective for COVID-19 Drug Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Parenteral Administration, Nasal Administration and Other Administrations for the Years 2025 & 2030
  • BRAZIL
    • TABLE 144: Brazil Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Product - Prefilled Syringe, Needle-free Injectors, Inhalers and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 145: Brazil 6-Year Perspective for COVID-19 Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled Syringe, Needle-free Injectors, Inhalers and Patches for the Years 2025 & 2030
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil 6-Year Perspective for COVID-19 Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2025 & 2030
    • TABLE 148: Brazil Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Route Of Administration - Parenteral Administration, Nasal Administration and Other Administrations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 149: Brazil 6-Year Perspective for COVID-19 Drug Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Parenteral Administration, Nasal Administration and Other Administrations for the Years 2025 & 2030
  • MEXICO
    • TABLE 150: Mexico Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Product - Prefilled Syringe, Needle-free Injectors, Inhalers and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 151: Mexico 6-Year Perspective for COVID-19 Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled Syringe, Needle-free Injectors, Inhalers and Patches for the Years 2025 & 2030
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico 6-Year Perspective for COVID-19 Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2025 & 2030
    • TABLE 154: Mexico Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Route Of Administration - Parenteral Administration, Nasal Administration and Other Administrations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 155: Mexico 6-Year Perspective for COVID-19 Drug Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Parenteral Administration, Nasal Administration and Other Administrations for the Years 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 156: Rest of Latin America Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Product - Prefilled Syringe, Needle-free Injectors, Inhalers and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 157: Rest of Latin America 6-Year Perspective for COVID-19 Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled Syringe, Needle-free Injectors, Inhalers and Patches for the Years 2025 & 2030
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America 6-Year Perspective for COVID-19 Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2025 & 2030
    • TABLE 160: Rest of Latin America Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Route Of Administration - Parenteral Administration, Nasal Administration and Other Administrations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 161: Rest of Latin America 6-Year Perspective for COVID-19 Drug Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Parenteral Administration, Nasal Administration and Other Administrations for the Years 2025 & 2030
  • MIDDLE EAST
    • COVID-19 Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 162: Middle East Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 163: Middle East 6-Year Perspective for COVID-19 Drug Delivery Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2025 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Product - Prefilled Syringe, Needle-free Injectors, Inhalers and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East 6-Year Perspective for COVID-19 Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled Syringe, Needle-free Injectors, Inhalers and Patches for the Years 2025 & 2030
    • TABLE 166: Middle East Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 167: Middle East 6-Year Perspective for COVID-19 Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2025 & 2030
    • TABLE 168: Middle East Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Route Of Administration - Parenteral Administration, Nasal Administration and Other Administrations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 169: Middle East 6-Year Perspective for COVID-19 Drug Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Parenteral Administration, Nasal Administration and Other Administrations for the Years 2025 & 2030
  • IRAN
    • TABLE 170: Iran Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Product - Prefilled Syringe, Needle-free Injectors, Inhalers and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Iran 6-Year Perspective for COVID-19 Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled Syringe, Needle-free Injectors, Inhalers and Patches for the Years 2025 & 2030
    • TABLE 172: Iran Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 173: Iran 6-Year Perspective for COVID-19 Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2025 & 2030
    • TABLE 174: Iran Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Route Of Administration - Parenteral Administration, Nasal Administration and Other Administrations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 175: Iran 6-Year Perspective for COVID-19 Drug Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Parenteral Administration, Nasal Administration and Other Administrations for the Years 2025 & 2030
  • ISRAEL
    • TABLE 176: Israel Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Product - Prefilled Syringe, Needle-free Injectors, Inhalers and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Israel 6-Year Perspective for COVID-19 Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled Syringe, Needle-free Injectors, Inhalers and Patches for the Years 2025 & 2030
    • TABLE 178: Israel Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 179: Israel 6-Year Perspective for COVID-19 Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2025 & 2030
    • TABLE 180: Israel Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Route Of Administration - Parenteral Administration, Nasal Administration and Other Administrations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 181: Israel 6-Year Perspective for COVID-19 Drug Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Parenteral Administration, Nasal Administration and Other Administrations for the Years 2025 & 2030
  • SAUDI ARABIA
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Product - Prefilled Syringe, Needle-free Injectors, Inhalers and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia 6-Year Perspective for COVID-19 Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled Syringe, Needle-free Injectors, Inhalers and Patches for the Years 2025 & 2030
    • TABLE 184: Saudi Arabia Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 185: Saudi Arabia 6-Year Perspective for COVID-19 Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2025 & 2030
    • TABLE 186: Saudi Arabia Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Route Of Administration - Parenteral Administration, Nasal Administration and Other Administrations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 187: Saudi Arabia 6-Year Perspective for COVID-19 Drug Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Parenteral Administration, Nasal Administration and Other Administrations for the Years 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 188: UAE Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Product - Prefilled Syringe, Needle-free Injectors, Inhalers and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: UAE 6-Year Perspective for COVID-19 Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled Syringe, Needle-free Injectors, Inhalers and Patches for the Years 2025 & 2030
    • TABLE 190: UAE Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 191: UAE 6-Year Perspective for COVID-19 Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2025 & 2030
    • TABLE 192: UAE Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Route Of Administration - Parenteral Administration, Nasal Administration and Other Administrations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 193: UAE 6-Year Perspective for COVID-19 Drug Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Parenteral Administration, Nasal Administration and Other Administrations for the Years 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Product - Prefilled Syringe, Needle-free Injectors, Inhalers and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East 6-Year Perspective for COVID-19 Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled Syringe, Needle-free Injectors, Inhalers and Patches for the Years 2025 & 2030
    • TABLE 196: Rest of Middle East Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 197: Rest of Middle East 6-Year Perspective for COVID-19 Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2025 & 2030
    • TABLE 198: Rest of Middle East Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Route Of Administration - Parenteral Administration, Nasal Administration and Other Administrations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 199: Rest of Middle East 6-Year Perspective for COVID-19 Drug Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Parenteral Administration, Nasal Administration and Other Administrations for the Years 2025 & 2030
  • AFRICA
    • COVID-19 Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 200: Africa Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Product - Prefilled Syringe, Needle-free Injectors, Inhalers and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Africa 6-Year Perspective for COVID-19 Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled Syringe, Needle-free Injectors, Inhalers and Patches for the Years 2025 & 2030
    • TABLE 202: Africa Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 203: Africa 6-Year Perspective for COVID-19 Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2025 & 2030
    • TABLE 204: Africa Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Route Of Administration - Parenteral Administration, Nasal Administration and Other Administrations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 205: Africa 6-Year Perspective for COVID-19 Drug Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Parenteral Administration, Nasal Administration and Other Administrations for the Years 2025 & 2030

IV. COMPETITION